Journal Issue - Volume 18 Issue 5 (5 March 2007)
- Exubera: convincing evidence of patient acceptability needed
- Stephanie Amiel
- Published online on May 16, 2007
- DOI: 10.1002/psb.33 (p 13-17)
- Latest news and product developments
- Published online on May 16, 2007
- DOI: 10.1002/psb.34 (p 18-19)
- Dyspepsia: key considerations for cost‐effective management
- Jane Cawston, Norman Evans
- Published online on May 16, 2007
- DOI: 10.1002/psb.35 (p 21-30)
- Managing dysmenorrhoea
- Published online on May 16, 2007
- DOI: 10.1002/psb.36 (p 33-34)
- Recognition and management of actinic keratoses in primary care
- Rino Cerio
- Published online on May 16, 2007
- DOI: 10.1002/psb.37 (p 37-47)
- ACE inhibitors: their properties and role in hypertension
- Sze‐Yuan Ooi, Stephen Ball
- Published online on May 16, 2007
- DOI: 10.1002/psb.38 (p 48-61)
- Exubera: first inhaled insulin for the management of diabetes
- Anthony Barnett
- Published online on May 16, 2007
- DOI: 10.1002/psb.39 (p 63-71)
- Epilepsy: problems of diagnosis and recommended treatment
- Nicola Cooper, Morgan Feely
- Published online on May 16, 2007
- DOI: 10.1002/psb.40 (p 72-78)
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- New Product Reviews
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Useful Websites
- Less Suitable Drugs
- Send Us Your Feedback
Advertising and Sponsorship
Other Journals
